Atlantic Equities Adjusts Price Target on Johnson & Johnson to $170 From $167, Maintains Neutral Rating

News

HomeHome / News / Atlantic Equities Adjusts Price Target on Johnson & Johnson to $170 From $167, Maintains Neutral Rating